{"news_desk": "Business", "print_page": "1", "section_name": "Business Day", "subsection_name": null, "byline": {"contributor": "Stephanie Clifford contributed reporting.", "original": "By ANDREW POLLACK", "person": [{"rank": 1, "role": "reported", "firstname": "Andrew", "organization": "", "lastname": "POLLACK"}]}, "abstract": "Martin Shkreli, who was arrested on securities fraud charges involving his hedge funds, is ousted as chief executive of his second pharmaceutical company, KaloBios Pharmaceuticals; was previously removed as chief executive of Turin Pharmaceuticals.", "type_of_material": "News", "word_count": "955", "lead_paragraph": "KaloBios Pharmaceuticals is a California biotechnology company that Mr. Shkreli gained control of in November.", "pub_date": "2015-12-22T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Martin Shkreli Is Removed as C.E.O. From Another Company, KaloBios", "print_headline": "Shkreli Is Removed From C.E.O. Post of a 2nd Drug Maker "}, "snippet": "KaloBios Pharmaceuticals is a California biotechnology company that Mr. Shkreli gained control of in November.", "multimedia": [{"height": 126, "url": "images/2015/12/22/business/22shkreli-web1/22shkreli-web1-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/12/22/business/22shkreli-web1/22shkreli-web1-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 400, "url": "images/2015/12/22/business/22shkreli-web1/22shkreli-web1-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2015/12/22/business/22shkreli-web1/22shkreli-web1-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/12/22/business/22shkreli-web1/22shkreli-web1-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/12/22/business/22shkreli-web1/22shkreli-web1-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/12/22/business/martin-shkreli-kalobios-pharmaceuticals-turing.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Shkreli, Martin (1983- )", "name": "persons"}, {"rank": "2", "is_major": "Y", "value": "KALOBIOS PHARMACEUTICALS INC.", "name": "organizations"}, {"rank": "3", "is_major": "Y", "value": "Securities and Commodities Violations", "name": "subject"}, {"rank": "4", "is_major": "Y", "value": "Turing Pharmaceuticals AG", "name": "organizations"}, {"rank": "5", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}], "blog": [], "_id": "56781b9538f0d80a0f1da8e2", "source": "The New York Times"}